Healthcare & Medical
AI Score 58/100

Turnkey Swiss-Made Biohacking Brand for Mental Performance – Ready to Launch

Switzerland

Availability unverified since 23 August 2026. The source portal blocks our checks; confirm with us before relying on it.

Annual revenue
Not disclosed
EBITDA margin
Not disclosed
Employees
Not disclosed
Asking price
Sign in to view

About this business

A turnkey Swiss-made neurobotanical brand in the high-growth biohacking/mental performance segment, fully developed with brand assets, formulations, and distribution infrastructure. Strong product fundamentals and dual go-to-market pathways support valuation, but absence of revenue/EBITDA data, unknown location, and lack of succession urgency signals create execution risk and uncertainty around true profitability. Score: 58/100, Industry: 18/25, Pricing: 16/25, Geography: 5/20, Urgency: 4/15, Quality: 15/15 --- Une marque neurobotanique suisse clés en main dans le segment en croissance du biohacking et de la performance mentale, complètement développée avec actifs de marque, formules et infrastructure de distribution. Les fondamentaux solides du produit et les deux canaux de mise sur le marché soutiennent la valorisation, mais l'absence de données de chiffre d'affaires/EBITDA, une localisation inconnue et l'absence de signaux d'urgence de succession créent un risque d'exécution et une incertitude quant à la véritable rentabilité.

Full description available after signup.

Sale & handover

Handover terms and reason for sale available after signup.

Highlights & considerationsAI-compiled

Growth opportunities

  • →Direct market launch
  • →B2B integration partnerships
  • →E commerce scaling
  • →Geographic expansion
  • →Pharmaceutical development
  • →Distribution partnerships
  • →Health practitioner network
  • →Subscription model
  • →Product line extension

Key assets

  • ·Brand
  • ·IP
  • ·Proprietary technology
  • ·Trademarks
  • ·Website
  • ·E commerce platform
  • ·Manufacturing partnerships
  • ·Product design
  • ·Formulations
  • ·Customer acquisition framework

Considerations

  • ·Key person dependency
  • ·No revenue history
  • ·Market validation lacking
  • ·Regulatory risk
  • ·Competitive market
  • ·Dependence on contract manufacturer
  • ·Early stage brand
  • ·Limited operational track record

Compiled by Alpine Business from the listing and public sources. Verify all points during due diligence.

What you'll see after signing the NDA

  • → Exact revenue, EBITDA, and asking price
  • → Full business description and operational details
  • → Seller contact information
  • → Customer concentration and key revenue sources
  • → Reason for sale and ideal buyer profile
  • → Direct introduction to the seller
  • → Request further documentation through Alpine

Confidential. Legally binding under Swiss law. Free.

Similar businesses for sale